4th Quarter - Report
PARATEK PHARMACEUTICALS for PARATEK PHARMACEUTICALS
Client
Income
—
Expenses
$20,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
FY 26 DOD Appropriations FY 26 HHS Appropriations Biodefense Funding
Foreign entity interest: Private Equity firm investment in the company.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BENJAMIN NOVAK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.